Antifibrotic Properties of Transarterial Oncolytic VSV Therapy for Hepatocellular Carcinoma in Rats With Thioacetamide-Induced Liver Fibrosis

Recombinant vesicular stomatitis virus (VSV) shows promise for the treatment of hepatocellular carcinoma (HCC), but its safety and efficacy when administered in a setting of hepatic fibrosis, which occurs in the majority of clinical cases, is unknown. We hypothesized that VSV could provide a novel b...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Altomonte, Jennifer, Marozin, Sabrina, De Toni, Enrico N, Rizzani, Antonia, Esposito, Irene, Steiger, Katja, Feuchtinger, Annette, Hellerbrand, Claus, Schmid, Roland M, Ebert, Oliver
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Nature Publishing Group 2013
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3831039/
https://ncbi.nlm.nih.gov/pubmed/23939023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2013.181
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak